InsidersTradesSigma
Follow the 하이텍팜 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 하이텍팜 has published 8 public disclosures. Market capitalisation: €114.4bn. The latest transaction was disclosed on 12 August 2026 (Purchase). Among the most active insiders: 차현준. All data is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
2 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,166 of 29,063 companies
76.4
score / 100
Value87
Quality66
FCF yld13%
Earn yld9.9%
EV/EBITDA6.0x
ROE7.2%
Gross mgn24%
Net mgn16%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations8 total
Other
200,000 sharesKRXDART:20260331004193
3,159 sharesKRXDART:20260330001084
8 of 8 declarations
About 하이텍팜
하이텍팜 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.